SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gujarat Inject (Kerala) informs about outcome of board meeting

31 Oct 2022 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Inject (Kerala) has informed that the Board of Directors of the Company in their Meeting held today October 31, 2022 at the Administrative Office of the Company at SB-06, Paradise Complex, Opp. M.S. University, Sayajiganj, Vadodara - 390005 Gujarat India which commenced at 03:00 pm and concluded at 03.15 pm to took note of the withdrawal of the Issue of Convertible Equity Warrants (‘Warrants/Convertible Warrants’) on preferential basis approved in the board meeting dated September 14, 2022 due to postponement of object of the Issue.

The above information is a part of company’s filings submitted to BSE.

Guj. Inject (Kerala) Share Price

89.95 -0.05 (-0.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×